Suppr超能文献

从G蛋白偶联受体结构解析到合理药物设计。

From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.

作者信息

Jazayeri Ali, Dias Joao M, Marshall Fiona H

机构信息

From Heptares Therapeutics Limited, BioPark, Broadwater Road, Welwyn Garden City AL7 3AX, United Kingdom

From Heptares Therapeutics Limited, BioPark, Broadwater Road, Welwyn Garden City AL7 3AX, United Kingdom.

出版信息

J Biol Chem. 2015 Aug 7;290(32):19489-95. doi: 10.1074/jbc.R115.668251. Epub 2015 Jun 22.

DOI:10.1074/jbc.R115.668251
PMID:26100628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4528114/
Abstract

A number of recent technical solutions have led to significant advances in G protein-coupled receptor (GPCR) structural biology. Apart from a detailed mechanistic view of receptor activation, the new structures have revealed novel ligand binding sites. Together, these insights provide avenues for rational drug design to modulate the activities of these important drug targets. The application of structural data to GPCR drug discovery ushers in an exciting era with the potential to improve existing drugs and discover new ones. In this review, we focus on technical solutions that have accelerated GPCR crystallography as well as some of the salient findings from structures that are relevant to drug discovery. Finally, we outline some of the approaches used in GPCR structure based drug design.

摘要

近期的一些技术解决方案推动了G蛋白偶联受体（GPCR）结构生物学的重大进展。除了对受体激活有详细的机制性认识外，新结构还揭示了新的配体结合位点。这些见解共同为合理药物设计提供了途径，以调节这些重要药物靶点的活性。将结构数据应用于GPCR药物发现开启了一个令人兴奋的时代，有望改进现有药物并发现新药物。在本综述中，我们重点关注加速GPCR晶体学研究的技术解决方案以及与药物发现相关的一些重要结构发现。最后，我们概述了基于GPCR结构的药物设计中使用的一些方法。

相似文献

1
From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.
J Biol Chem. 2015 Aug 7;290(32):19489-95. doi: 10.1074/jbc.R115.668251. Epub 2015 Jun 22.
2
Novel Allosteric Modulators of G Protein-coupled Receptors.
J Biol Chem. 2015 Aug 7;290(32):19478-88. doi: 10.1074/jbc.R115.662759. Epub 2015 Jun 22.
3
Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology.
J Biol Chem. 2015 Aug 7;290(32):19469-70. doi: 10.1074/jbc.R115.675728. Epub 2015 Jun 30.
4
GPCR structures in drug design, emerging opportunities with new structures.
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4073-9. doi: 10.1016/j.bmcl.2014.07.009. Epub 2014 Jul 10.
5
Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
Curr Top Med Chem. 2014;14(15):1842-63. doi: 10.2174/1568026614666140901130843.
6
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
J Med Chem. 2019 Jan 10;62(1):24-45. doi: 10.1021/acs.jmedchem.7b01844. Epub 2018 Feb 26.
7
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Int J Mol Sci. 2021 Feb 10;22(4):1763. doi: 10.3390/ijms22041763.
8
GPCR profiling: from hits to leads and from genotype to phenotype.
Drug Discov Today Technol. 2015 Nov;18:30-7. doi: 10.1016/j.ddtec.2015.10.005. Epub 2015 Nov 6.
9
Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Pharmacol Ther. 2022 Sep;237:108242. doi: 10.1016/j.pharmthera.2022.108242. Epub 2022 Jul 18.
10
Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
Trends Pharmacol Sci. 2017 Sep;38(9):837-847. doi: 10.1016/j.tips.2017.05.010. Epub 2017 Jun 22.

引用本文的文献

1
Phytotherapeutic potential of (Mart.) O. Berg: antitumor effects in vitro and in silico, with emphasis on SK-MEL-28 melanoma cells-a study on leaf and fruit infusions.
In Silico Pharmacol. 2024 Nov 19;12(2):105. doi: 10.1007/s40203-024-00286-1. eCollection 2024.
2
In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches.
Sci Rep. 2023 Dec 4;13(1):21404. doi: 10.1038/s41598-023-48398-6.
3
G protein-coupled receptor-targeting antibody-drug conjugates: Current status and future directions.
Cancer Lett. 2023 Jun 28;564:216191. doi: 10.1016/j.canlet.2023.216191. Epub 2023 Apr 25.
4
Pharmacokinetic and molecular docking studies to design antimalarial compounds targeting Actin I.
Int J Health Sci (Qassim). 2021 Nov-Dec;15(6):4-15.
5
How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs.
Int J Mol Sci. 2020 Aug 18;21(16):5933. doi: 10.3390/ijms21165933.
6
Identifying GPCR-drug interaction based on wordbook learning from sequences.
BMC Bioinformatics. 2020 Apr 20;21(1):150. doi: 10.1186/s12859-020-3488-8.
7
Characterizing Interhelical Interactions of G-Protein Coupled Receptors with the Fragment Molecular Orbital Method.
J Chem Theory Comput. 2020 Apr 14;16(4):2814-2824. doi: 10.1021/acs.jctc.9b01136. Epub 2020 Mar 9.
8
Toward G protein-coupled receptor structure-based drug design using X-ray lasers.
IUCrJ. 2019 Oct 24;6(Pt 6):1106-1119. doi: 10.1107/S2052252519013137. eCollection 2019 Nov 1.
9
Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery.
Int J Mol Sci. 2019 Aug 29;20(17):4237. doi: 10.3390/ijms20174237.
10
Prediction of Conformation Specific Thermostabilizing Mutations for Class A G Protein-Coupled Receptors.
J Chem Inf Model. 2019 Sep 23;59(9):3744-3754. doi: 10.1021/acs.jcim.9b00175. Epub 2019 Aug 27.

本文引用的文献

1
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling.
Cell. 2015 May 21;161(5):1101-1111. doi: 10.1016/j.cell.2015.04.043. Epub 2015 May 14.
2
Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.
Cell. 2015 May 7;161(4):833-44. doi: 10.1016/j.cell.2015.04.011. Epub 2015 Apr 23.
3
Two disparate ligand-binding sites in the human P2Y1 receptor.
Nature. 2015 Apr 16;520(7547):317-21. doi: 10.1038/nature14287. Epub 2015 Mar 30.
4
Methodological advances: the unsung heroes of the GPCR structural revolution.
Nat Rev Mol Cell Biol. 2015 Feb;16(2):69-81. doi: 10.1038/nrm3933. Epub 2015 Jan 15.
5
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.
Nature. 2015 Mar 12;519(7542):247-50. doi: 10.1038/nature14035. Epub 2014 Dec 22.
6
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.
Nat Rev Drug Discov. 2014 Sep;13(9):692-708. doi: 10.1038/nrd4308.
7
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.
Nature. 2014 Sep 4;513(7516):124-7. doi: 10.1038/nature13494. Epub 2014 Jul 20.
8
Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain.
Nature. 2014 Jul 31;511(7511):557-62. doi: 10.1038/nature13396. Epub 2014 Jul 6.
9
Biased ligands at G-protein-coupled receptors: promise and progress.
Trends Pharmacol Sci. 2014 Jul;35(7):308-16. doi: 10.1016/j.tips.2014.04.007. Epub 2014 May 28.
10
Agonist-bound structure of the human P2Y12 receptor.
Nature. 2014 May 1;509(7498):119-22. doi: 10.1038/nature13288.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验